Results 121 to 130 of about 13,106 (183)

Integrating multi-omics, machine learning, and molecular dynamics simulations to identify glutamate metabolism-related biomarkers and drug candidates in rheumatoid arthritis. [PDF]

Front Mol Biosci
Zhu B, Li B, Zhang S, Qi W, Mu Z, Kong P, Han Y, Shi Z.   +7 more
europepmc   +1 more source

Novel approaches for separating graft-versus-leukemia effects from graft-versus-host disease. [PDF]

Front Oncol
Hasegawa Y, Teshima T, Hashimoto D.
europepmc   +1 more source

Maintenance Therapy in Acute Myeloid Leukemia: Current Perspectives and Future Directions. [PDF]

Curr Oncol
Velarde P, Aloufi A, Sanford D.
europepmc   +1 more source

From monoclonals to bispecific T cell engagers: the evolving antibody-based therapy landscape in acute myeloid leukemia. [PDF]

Front Immunol
Rasouli M, Dalem M, Raaijmakers MHGP, Katsikis PD, Erkeland SJ.   +4 more
europepmc   +1 more source

Phase 2 study of azacitidine plus pembrolizumab as second-line treatment in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma. [PDF]

Oncologist
Safyan RA, White RA, Gonda TA, Lee SM, Han J, Kuriakose N, Yamamoto NK, Kugel S, Jamison JK, Manji GA, Schwartz GJ, Oberstein PE, Bates SE.   +12 more
europepmc   +1 more source

Targeted Therapy in Acute Myeloid Leukemia: Current Approaches and Novel Directions. [PDF]

J Pers Med
Ko KH, Gelfer R, Wheat JC, Cai SF.
europepmc   +1 more source

Hypomethylating agents plus venetoclax in younger acute myeloid leukemia: Meta-analysis of a shifting treatment paradigm. [PDF]

Cancer
Perrone S, De Fazio L, Monachetti S, Molica M.   +3 more
europepmc   +1 more source

Connective tissue diseases combined with chronic myelomonocytic leukemia and myelofibrosis: a case report and literature review. [PDF]

Front Immunol
Yin HQ, Jin S, Fu Y, Zhu HL, Li XF.
europepmc   +1 more source

American Society of Hematology 2025 guidelines for treating newly diagnosed acute myeloid leukemia in older adults. [PDF]

Blood Adv
Sekeres MA, Mattison R, Artz A, Baer MR, Chua CC, Demichelis-Gómez R, Egan PC, Fletcher L, Foucar C, Garcia JS, Gilberto L, Gómez de León A, Lancet J, Loh KP, Malcovati L, Marini B, Platzbecker U, Sorror ML, Tinsley-Vance S, Treitz J, Oliveros MJ, Ibrahim S, Roldan Y, Guyatt G, Brignardello-Petersen R.   +24 more
europepmc   +1 more source

Early Transplantation After Pretransplant Reduction of <i>TP53</i>-Altered Clones and Prolonged Dose-Adjusted Azacitidine Maintenance: A Three-Case Series. [PDF]

EJHaem
Yamagata F, Yoshihara K, Nannya Y, Samori M, Takahashi S, Kumamoto T, Fujita Y, Utsunomiya N, Yoshihara S.   +8 more
europepmc   +1 more source